Comparison of Ga-68-DOTATOC and F-18-FDG in patients with neuroendocrine tumors

被引:0
|
作者
Koukouraki, S. [1 ]
Dimitrakopoulou-Strauss, A. [1 ]
Georgoulias, V. [2 ]
Schuhmacher, J. [1 ]
Haberkorn, U. [1 ]
Strauss, L. G. [1 ]
机构
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Univ Crete, Dept Oncol, Iraklion, Crete, Greece
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S53 / S54
页数:2
相关论文
共 50 条
  • [1] Clinical application of Ga-68-DOTATOC in 132 Patients with neuroendocrine tumors.
    Hofmann, M.
    Boerner, A.
    Krause, T.
    Weidner, S.
    Knoop, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S53 - S53
  • [2] The Role of Combined 68Ga-DOTATOC and 18F-FDG PET/CT in Patients with Pancreatic Neuroendocrine Tumors
    Tamburrino, D.
    Rinzivillo, M.
    Maurizi, A.
    Capurso, G.
    Partelli, S.
    Panzuto, F.
    Salgarello, M.
    Delle Fave, G.
    Falconi, M.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 264 - 264
  • [3] Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    Sophia Koukouraki
    Ludwig G. Strauss
    Vassilios Georgoulias
    Michael Eisenhut
    Uwe Haberkorn
    Antonia Dimitrakopoulou-Strauss
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 1115 - 1122
  • [4] Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
    Koukouraki, Sophia
    Strauss, Ludwig G.
    Georgoulias, Vassilios
    Eisenhut, Michael
    Haberkorn, Uwe
    Dimitrakopoulou-Strauss, Antonia
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (10) : 1115 - 1122
  • [5] Ga-68-DOTATOC molecular modelling in carcinoid tumors.
    Hofmann, M.
    Weitzel, T.
    Weidner, S.
    Corminboeuf, F.
    Meacke, H.
    Krause, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S372 - S372
  • [6] Ga-68-DOTATOC molecular modelling in carcinoid tumors.
    Hofmann, M.
    Weitzel, T.
    Weidner, S.
    Corminboeuf, F.
    Meacke, H.
    Krause, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S177 - S177
  • [7] Intrapancreatic Accessory Spleen: A Differential Diagnosis to Neuroendocrine Tumors of the Pancreas on Ga-68-DOTATOC PET/CT
    Fuelber, Isabelle
    Wursterl, Christoph
    Librizzi, Damiano
    Roessler, Marion
    Gallmeier, Eike
    Bartsch, Detlef K.
    JOURNAL OF THE PANCREAS, 2016, 17 (04): : 427 - 430
  • [8] A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
    Kayani, Irfan
    Conry, Brendon G.
    Groves, Ashley M.
    Win, Thida
    Dickson, John
    Caplin, Martyn
    Bomanji, Jamshed B.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (12) : 1927 - 1932
  • [9] Quantitative 68Ga-DOTATOC PET in patients with neuroendocrine tumors
    Koukouraki, S.
    Dimitrakopoulou-Strauss, A.
    Georgoulias, V.
    Schuhmacher, J.
    Haberkorn, U.
    Strauss, L. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S115 - S115
  • [10] Automated Dispenser for Ga-68-DOTATOC Radiopharmaceuticals
    Li, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S467 - S467